Baker Biotech Capital (GP), LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a Director in NEUROGEN CORP ($NRGN) and a 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and a 10% Owner in PHARMACYCLICS INC ($PCYC) and a 10% Owner in VIROPHARMA INC ($VPHM) and a 10% Owner in ADOLOR CORP ($ADLR) and a 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).

Address: 667 MADISON AVENUE, 17TH FLOOR NEW YORK US 10021 NY

Companies in which Baker Biotech Capital (GP), LLC is an Insider

ADOLOR CORP

Trading Symbol: ADLR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 79,054 shares
Latest Transaction: Oct 29 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ALLOS THERAPEUTICS INC

Trading Symbol: ALTH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 2,022,293 shares
Latest Transaction: Feb 06 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ardea Biosciences, Inc./DE

Trading Symbol: IBPI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 1,646,964 shares
Latest Transaction: Dec 19 2008

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

AUXILIUM PHARMACEUTICALS INC

Trading Symbol: AUXL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 844,839 shares
Latest Transaction: Aug 03 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 1,522,015 shares
Current Value: $8,629,825
Latest Transaction: Jun 01 2009
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENOMIC HEALTH INC

Trading Symbol: GHDX
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 1,253,653 shares
Current Value: $34,462,921
Latest Transaction: Aug 17 2009
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IDERA PHARMACEUTICALS, INC.

Trading Symbol: IDRA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 209,110 shares
Current Value: $326,212
Latest Transaction: Jul 30 2008
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

INCYTE CORP

Trading Symbol: INCY
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 2,933,021 shares
Current Value: $346,624,422
Latest Transaction: Sep 23 2010
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NEUROGEN CORP

Trading Symbol: NRGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 3,500,059 shares
Latest Transaction: Nov 13 2008

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PHARMACYCLICS INC

Trading Symbol: PCYC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 41,519 shares
Latest Transaction: Aug 24 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 4,626,213 shares
Current Value: $281,227,488
Latest Transaction: May 04 2010
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

VIROPHARMA INC

Trading Symbol: VPHM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 1,765,213 shares
Latest Transaction: May 13 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC

Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, IDRA, INCY, NRGN, PCYC, SGEN, VPHM

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 24 2011PCYCPHARMACYCLICS INCBaker Biotech Capital (GP), LL ...10% OwnerBuyP9.938,98789,21941,51932.5 K to 41.5 K (+27.63 %)
Aug 24 2011PCYCPHARMACYCLICS INCBaker Biotech Capital (GP), LL ...10% OwnerBuyP9.9729,956298,64032,5322.6 K to 32.5 K (+1,162.89 %)
Aug 24 2011PCYCPHARMACYCLICS INCBaker Biotech Capital (GP), LL ...10% OwnerBuyP10.007677,6692,5761.8 K to 2.6 K (+42.40 %)
Aug 03 2011AUXLAUXILIUM PHARMACEU ...Baker Biotech Capital (GP), LL ...10% OwnerSellS17.256,361109,715844,839851.2 K to 844.8 K (-0.75 %)
Aug 03 2011AUXLAUXILIUM PHARMACEU ...Baker Biotech Capital (GP), LL ...10% OwnerSellS18.0461,5191,109,735851,200912.7 K to 851.2 K (-6.74 %)
Aug 03 2011AUXLAUXILIUM PHARMACEU ...Baker Biotech Capital (GP), LL ...10% OwnerSellS18.0340,690733,620912,719953.4 K to 912.7 K (-4.27 %)
May 13 2011VPHMVIROPHARMA INCBaker Biotech Capital (GP), LL ...10% OwnerSellJ0.00522,80001,765,2132.3 M to 1.8 M (-22.85 %)

View all Baker Biotech Capital (GP), LLC insider transactions.

What Is Illegal Insider Trading?

Illegal Insider trading occurs when a trade has been influenced by the possession of "material" and "non-public" information about the security. Because such information is not available to other investors, a person using it is trying to gain an unfair advantage over others. More ...

How Companies Report Insider Transactions

Trading of stock is controlled by the Securities and Exchange Commission (SEC), an agency of the United States federal government. More ...

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

Contact us | Follow us on Twitter